10.00% p.a. Early Redemption Kick-In GOAL

Underlying: Bristol-Myers Squibb / Celgene Corporation / Regeneron Pharma SSPA/EUSIPA Product Type: Barrier Reverse Convertibles (1230, Auto-Callable) Valor: 38180407 / ISIN: CH0381804076

Last update 11.10.2018
  • Bid

    57.05 %
    Volume: 10'000

  • Ask

    58.05 %
    Volume: 10'000